Thomas P Potjer

7PUBLICATIONS
21CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 08, 2025
An Unexpected Case of Somatic Mosaicism of the Dutch p16-Leiden Founder Variant in the CDKN2A Gene.

M van der Meulen, J T van Wezel, D Terlouw

|Nov 27, 2024
Polygenic Risk Score Improves Melanoma Risk Assessment in a Patient Cohort from the Veneto Region of Italy.

Stefania Pellegrini, Thomas P Potjer, Paola Del Bianco

|Mar 29, 2024
SDHAF2-Linked Metastatic Paraganglioma: A Case Report with Implications for Counseling and Follow-Up of Pathogenic SDHAF2 Variant Carriers.

Monique A M de Jong, Eleonora P M Corssmit, Jeroen C Jansen

|Sep 30, 2020
Association between a 46-SNP Polygenic Risk Score and melanoma risk in Dutch patients with familial melanoma.

Thomas P Potjer, Tara W J van der Grinten, Inge M M Lakeman

|Nov 11, 2018
Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.

Thomas P Potjer, Sander Bollen, Anneliese J E M Grimbergen

|May 18, 2018
Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers.

Isaura Ibrahim, Babs G Sibinga Mulder, Bert Bonsing

Pageof 2

Frequent Collaborators

2 joint publications

Nienke van der Stoep

1 joint publications

M van der Meulen

1 joint publications

J T van Wezel

1 joint publications

D Terlouw